On September 13, 2018 Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology, reported that its management team will attend the following key investor and partnering conferences in the coming months (Press release, Onxeo, SEP 13, 2018, View Source [SID1234529680]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

European Large & Midcap Event

October 8-9, 2018

Paris, France

BIO-Europe

November 5-7, 2018

Copenhagen, Denmark

Boursocap / Les Echos – Investir Event

November 21, 2018

Paris, France

Investor meetings during the JP Morgan Healthcare Conference 2019

January 7-10, 2019

San Francisco, US

BioMed Event

January 22, 2019

Paris, France

180913_Onxeo_conferences_Q418_EN